相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study
Yogesh Yadav et al.
DIABETES OBESITY & METABOLISM (2022)
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial
R. A. Ajjan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Effect of AZD4017, a selective 11β-HSD1 inhibitor, on bone turnover markers in post-menopausal osteopenia
Afroze Abbas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
11 beta HSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
Rowan S. Hardy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Endogenous urinary glucocorticoid metabolites and mortality in prednisolone-treated renal transplant recipients
Annet Vulto et al.
CLINICAL TRANSPLANTATION (2020)
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Ida Pernicova et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
Nantia Othonos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
11 beta-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
Keira Markey et al.
BRAIN COMMUNICATIONS (2020)
11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy
C. G. Fenton et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Establishment of a healthy human range for the whole blood ‘OX40’ assay for the detection of antigen-specific CD4+ T cells by flow cytometry
Ross Sadler et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2014)
Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial
Renate E. van Genugten et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess
Stuart A. Morgan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels
Yoshihide Fujigaki
MEDICAL SCIENCE MONITOR (2014)
11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
Laura L. Gathercole et al.
ENDOCRINE REVIEWS (2013)
Prevalence of oral glucocorticoid usage in the United States: A general population perspective
Robert A. Overman et al.
ARTHRITIS CARE & RESEARCH (2013)
Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments
Pushpa Patel et al.
ENDOCRINE-RELATED CANCER (2012)
11β-Hydroxysteroid Dehydrogenase Type 1, But Not Type 2, Deficiency Worsens Acute Inflammation and Experimental Arthritis in Mice
Agnes E. Coutinho et al.
ENDOCRINOLOGY (2012)
Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans
Daniel H. van Raalte et al.
DIABETES CARE (2011)
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
P. U. Feig et al.
DIABETES OBESITY & METABOLISM (2011)
Effect of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog
Dale S. Edgerton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss
K. Kaur et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2010)
Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency
Gareth G. Lavery et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Local and systemic glucocorticoid metabolism in inflammatory arthritis
R. Hardy et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
11β-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues
Magalie Berthiaume et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
11β-hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation
M Eijken et al.
MOLECULAR ENDOCRINOLOGY (2005)
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study
PC Souverein et al.
HEART (2004)
11β-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone
MS Cooper et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
P Alberts et al.
DIABETOLOGIA (2002)
Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1
T Barf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure
MS Cooper et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice.
NM Morton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Use of oral corticosteroids in the United Kingdom
TP van Staa et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
分享论文
